XPO5 and neoplasm: Therefore, immunotherapy using mRNA vaccines targeting previously recognized tumor antigens (AUNIP, FANCI, LASP1, PSMD8, and XPO5) could induce immune cell infiltration to reinvigorate the ISI patient’s immune system.